Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
PLRX
Shares outstanding
61,031,708 shares
Disclosed Ownership
5,859,044 shares
Ownership
9.6%
Form type
SCHEDULE 13D
Filing time
10 Mar 2025, 17:24:28 UTC
Date of event
03 Mar 2025

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 9.6% ownership in Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share (PLRX) on 03 Mar 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D for Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share (PLRX).
  • Disclosed ownership: 9.6%.
  • Date of event: 03 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Mar 2025, 17:24.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 9.6% 5,859,044 0 5,859,044 /s/ Kevin Tang Manager 0001232621
KEVIN TANG 9.6% 5,859,044 0 5,859,044 /s/ Kevin Tang Self 0001178579
TANG CAPITAL PARTNERS, LP 5.4% 3,295,127 0 3,295,127 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner 0001191935
TANG CAPITAL PARTNERS INTERNATIONAL, LP 4.2% 2,563,917 0 2,563,917 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0002036763
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0002036770
CONCENTRA BIOSCIENCES, LLC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0001970065